Defining the composition of the outer surface of the coronavirus

Mapping the lipid envelope composition of SARS-CoV2 for reducing transmission, thrombosis, and inflammation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN54053617

Enrollment

100

Registered

2021-11-15

Start date

2021-12-01

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 (SARS-CoV-2 infection) Infections and Infestations

Interventions

Eligible participants will be identified in screening programmes undertaken routinely by Public Health Wales (PHW). PHW will only share positive PCR results of patients in the population of HB invol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adults (=18 years old) who have PCR-positive testing for COVID-19 in the last 5-days, who are able to provide written informed consent.

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

Measure	Time frame
SARS-CoV2 envelope characterisation, within 5 days of a positive PCR test (time Zero) , analysed using Mass Spectrometry Lipidomics following collection at a single timepoint	—

Secondary

Measure	Time frame
There are no secondary outcome measures	—

Countries

United Kingdom, Wales

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026